The analysis of any legal or medical billing is dependent on numerous specific facts — including the factual situations present related to the patients, the practice, the professionals and the medical services and advice. Additionally, laws and regulations and insurance and payer policies are subject to change. The information that has been accurate previously can be particularly dependent on changes in time or circumstances. The information contained in this web site is intended as general information only. It is not intended to serve as medical, health, legal or financial advice or as a substitute for professional advice of a medical coding professional, healthcare consultant, physician or medical professional, legal counsel, accountant or financial advisor. If you have a question about a specific matter, you should contact a professional advisor directly. CPT copyright American Medical Association. All rights reserved. CPT is a registered trademark of the American Medical Association.
Delaware Preferred Drug List
The Delaware Preferred Drug List (PDL) is a list of outpatient drugs that states encourage providers to prescribe over others, as a mechanism to negotiate higher supplemental rebates. The PDL was developed by the Pharmacy and Therapeutics (P&T) Committee in an effort to select both clinically sound and cost effective medications for use by those eligible for Medicaid benefits. The state may attach a higher copay or require prior authorization for drugs not on the PDL. The list is updated on a monthly basis.